A prophylactic treatment for the prevention or reduction in severity of Rhodococcusequi foal pneumonia. Clinical Results: 58% reduction in the incidence of R. equi pneumonia when all foals were given two doses of RhodococcusEqui Antibody in the first month of life.
Available frozen in: 1000ml, 500ml, 300ml bags
Evaluation of a commercially available hyperimmune plasma product for prevention of naturally acquired pneumonia caused by Rhodococcusequi in foals.Steeve Giguere, DVM; Jack Gaskin, DVM; Corey Miller, DVM; James Bowman, DVM, JAVMA, Vol 220, No 1, January 1, 2002.
